Zevra Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 05/08/2026 | Mar 2026Filed 05/08/2026 | Sep 2025Filed 05/11/2025 | Jun 2025Filed 05/08/2026 | Mar 2025Filed 05/08/2026 | Sep 2024Filed 05/11/2025 | Jun 2024Filed 05/11/2025 | Mar 2024Filed 05/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $40 | $36 | $26 | $26 | $20 | $3.7 | $4.4 | $3.4 | |
| $8.8 | $38 | −$0.5 | $75 | −$3.1 | −$33 | −$20 | −$17 | |
| $0.14 | $0.60 | −$0.01 | $1.21 | −$0.06 | −$0.69 | −$0.48 | −$0.40 | |
| 61 | 60 | 56 | 56 | 54 | 48 | 42 | 42 |
Trend